Key Financial Data Of Reporting Company

D.Western Therapeutics Institute, Inc. - Filing #7313030

Concept 2024-01-01 to
2024-06-30
As at
2024-06-30
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-06-30
As at
2023-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
223,522,000 JPY
428,364,000 JPY
187,710,000 JPY
Ordinary profit (loss)
-459,287,000 JPY
-796,363,000 JPY
-254,590,000 JPY
Net assets
856,001,000 JPY
1,279,764,000 JPY
1,820,908,000 JPY
Total assets
2,065,605,000 JPY
2,373,371,000 JPY
2,820,536,000 JPY
Basic earnings (loss) per share
-16.15
-25.56
-7.89
Diluted earnings per share
Equity-to-asset ratio
0.412 xbrli:pure
0.539 xbrli:pure
0.642 xbrli:pure
Net cash provided by (used in) operating activities
-790,794,000 JPY
-586,821,000 JPY
-142,683,000 JPY
Net cash provided by (used in) investing activities
-9,587,000 JPY
-15,254,000 JPY
-3,744,000 JPY
Net cash provided by (used in) financing activities
233,862,000 JPY
134,466,000 JPY
46,606,000 JPY
Cash and cash equivalents
1,301,058,000 JPY
1,867,264,000 JPY
2,235,105,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.